EcoDrugPlus

Coagulation Factor Ii Thrombin Receptor

Ensembl ID : ENSNBRG00000020103
Gene Symbol: F2R
2 Cross references
248 Possible Orthologues:

Coagulation Factor Vii-Like

Ensembl ID : ENSNBRG00000022469
Gene Symbol: LOC102785517
3 Cross references
78 Possible Orthologues:

Coagulation Factor X

Ensembl ID : ENSNBRG00000022444
Gene Symbol: F10
1 Cross references
234 Possible Orthologues:

Coagulation Factor X-Like

Ensembl ID : ENSNBRG00000022436
Gene Symbol: LOC102784942
3 Cross references
232 Possible Orthologues:

Coagulation Factor Xi-Like

Ensembl ID : ENSNBRG00000019652
Gene Symbol: LOC102789712
2 Cross references
211 Possible Orthologues:

Coiled-Coil Domain-Containing Protein 6-Like

Ensembl ID : ENSNBRG00000015495
Gene Symbol: LOC102799836
3 Cross references
207 Possible Orthologues:

Collagenase 3-Like

Ensembl ID : ENSNBRG00000002102
Gene Symbol: LOC102790342
3 Cross references
278 Possible Orthologues:

Complement C5-Like

Ensembl ID : ENSNBRG00000024311
Gene Symbol: LOC102779817
2 Cross references
216 Possible Orthologues:

Cyclin D1

Ensembl ID : ENSNBRG00000010664
Gene Symbol: CCND1
3 Cross references
206 Possible Orthologues:

Cyclin-Dependent Kinase 1-Like

Ensembl ID : ENSNBRG00000019289
Gene Symbol: LOC102793425
3 Cross references
246 Possible Orthologues:

Cyclin-Dependent Kinase 2-Like

Ensembl ID : ENSNBRG00000010772
Gene Symbol: LOC102800123
3 Cross references
202 Possible Orthologues:

Cyclin-Dependent Kinase 4-Like

Ensembl ID : ENSNBRG00000010216
Gene Symbol: LOC102796531
3 Cross references
238 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).